How Bio-based Dimethyl Fumarate is Produced
Key Pathways:
- Fermentation of Sugars to Fumaric Acid
- Engineered fungi like Rhizopus oryzae convert glucose or xylose into fumaric acid via the tricarboxylic acid (TCA) overflow pathway.
- Esterification with Bio-Methanol
- Fumaric acid is esterified with bio-methanol (from renewable methanol or syngas) using acidic catalysts to produce dimethyl fumarate.
- Alternative Feedstock Routes
- Some research explores direct microbial or chemo-catalytic synthesis of esters, but fumaric acid esterification remains the most mature route.
Feedstocks: Corn glucose, lignocellulosic hydrolysates, bio-methanol.
Case Study: DSM – Bio-based Fumaric Acid for Pharma Applications
Highlights:
- DSM developed fermentation technology to produce high-purity fumaric acid for pharmaceutical and food use.
- Enables downstream synthesis of dimethyl fumarate with lower environmental footprint.
- Supported formulation of Tecfidera®, a dimethyl fumarate-based drug for MS (though API manufacturing is separate).
Timeline & Outcome:
- 2009: DSM begins work on fermentation-based fumaric acid.
- 2013–2015: Process refined for food- and pharma-grade purity.
- 2016–2022: Collaboration with API makers on bio-DMFum integration for regulated markets.
- 2023: DSM’s bio-platform part of larger health and nutrition strategy post-spin-off.
Global Startups Working on Bio-based Dimethyl Fumarate
- BioAmber (USA/Canada) – Previously produced bio-succinic and explored fumaric acid via similar platforms.
- Myriant (USA) – Developed dicarboxylic acid fermentations, including fumaric acid derivatives.
- DSM (Netherlands) – Advanced bio-fumaric acid platform as precursor to dimethyl fumarate.
- ElevenEs (Serbia) – Exploring bio-based fumarate esters for battery and polymer applications.
India’s Position
India has the following enabling conditions:
- Established glucose fermentation infrastructure via bio-succinic acid and citric acid manufacturers.
- Use of dimethyl fumarate in pharmaceutical manufacturing (e.g., Tecfidera generics) positions India as a future player in bio-DMFum API pathways.
- No domestic commercial production of bio-DMFum yet, but capability exists with bio-acid and bio-methanol advances.
Commercialization Outlook
Market & Demand
- Dimethyl fumarate market: ~$180–220 million globally (2024), driven mainly by:
- Polymer additives (heat stabilizers, plasticizers)
- Fungicides and coatings
Key Drivers
- Growing demand for non-phthalate plasticizers and stabilizers.
- Regulatory mandates on greener pharma ingredients and excipients.
- Push for bio-based solvents and specialty esters.
- Availability of bio-methanol and fermentation-based acids.
Challenges to Address
- Purity and Yield: Pharma-grade DMFum requires stringent specifications.
- Cost Gap: Bio-DMFum costs ~25–40% more than fossil routes due to upstream bio-acid processing.
- Limited Market Awareness: DMFum often perceived as a niche intermediate.
- Regulatory Barriers: Bio-based versions need equivalence validation in pharma APIs.
Progress Indicators
- 2009–2015: DSM commercializes food/pharma-grade bio-fumaric acid.
- 2016–2020: Integration with esterification partners for high-purity DMFum.
- 2021–2023: Bio-DMFum evaluated in cosmetic and pharma-grade supply chains.
- India: No pilot/demo bio-DMFum plants yet; bio-methanol and organic acid platforms under development.
Bio-based dimethyl fumarate via fermentation and esterification is at TRL 7–8, with commercial fumaric acid and esterification proven at industrial scale. Direct microbial DMFum synthesis remains at TRL 4–5.
Conclusion
Bio-based dimethyl fumarate represents a valuable bridge between green fermentation processes and high-value chemical applications, especially in pharmaceuticals and polymer additives. Companies like DSM and Myriant have demonstrated the viability of bio-fumaric acid production, making the downstream bio-DMFum conversion commercially feasible. India’s strengths in fermentation and pharma manufacturing make it a natural candidate for future leadership. As bio-methanol availability improves and sustainability standards rise, renewable dimethyl fumarate could gain significant traction across regulated and industrial markets.
Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in
Expert Consulting Assistance for Indian Bioenergy & Biomaterials
Talk to BioBiz
Call Muthu – 9952910083
Email – ask@biobiz.in
